Table 3.
Serotype distribution per specimen
| Total number of samples | Samples included in PCV13* number (%) | Serotypes (n)† | |
|---|---|---|---|
| Blood | 21 | 18 (86) | 1 (4), 14 (3), 19A (3), 19F (3), 23A (1), 23F (2), 34 (1), 38 (1), 6AB (1), 7F (1), 9V (1) |
| Cerebrospinal fluid | 4 | 1 (25) | 18C (1), 24F (2), 34 (1) |
| Joint fluid | 1 | 1 (100) | 23F (1) |
| Upper respiratory samples‡ | 6 | 4 (67) | 11A (1), 14 (1), 19A (2), 19F (1), 23F (1), 35B (1) |
| Lower respiratory samples§ | 133 | 74 (56) | 10A (1), 11A (2), 12F (1), 13 (4), 14 (4), 15A (2), 15BC (4), 17F (1), 18 (1), 19A (5), 19F (25), 20 (1), 21 (1), 22F (2), 23F (22), 3 (1), 34 (20), 35A (4), 35B (2), 35F (4), 38 (1), 6AB (16), 6C (2), 9V (1), non-typeable (6) |
| Total | 166 | 99 (60) | 1 (4), 10A (1), 11A (3), 12F (1), 13 (4), 14 (8), 15A (2), 15BC (4), 17F (1), 18 (1), 18C (1), 19A (10), 19F (29), 20 (1), 21 (1), 22F (2), 23A (1), 23F (26), 24F (2), 3 (1), 34 (22), 35A (4), 35B (3), 35F (4), 38 (2), 6AB (17), 6C (2), 7F (1), 9V (6), non-typeable (6) |
*
Serotypes included in PCV13—13-valent pneumococcal conjugate vaccine.
†
Serotypes included in PCV13 are marked in bold.
‡
Upper respiratory samples: ear, eye, and nasopharyngeal swab.
§
Lower respiratory samples: sputum or bronchoalveolar fluid.